Oops, you're using an old version of your browser so some of the features on this page may not be displaying properly.

MINIMAL Requirements: Google Chrome 24+Mozilla Firefox 20+Internet Explorer 11Opera 15–18Apple Safari 7SeaMonkey 2.15-2.23

Poster display session

4147 - Role of an intronic polymorphism in the CREB1 gene, involved in melanogenesis, with the risk and the aggressiveness of cutaneous melanoma


10 Sep 2017


Poster display session


Cancers in Adolescents and Young Adults (AYA);  Translational Research;  Melanoma


Janet Silva


Annals of Oncology (2017) 28 (suppl_5): v428-v448. 10.1093/annonc/mdx377


J.K. Silva1, C. Oliveira1, B. Sá Carvalho2, C. Torricelli1, G.V.B. Gomez1, W.D.L. Oliveira1, J.A. Rinck-Junior3, A.M. Moraes3, M.M. Ortega4, C.S.P. Lima3, G.J. Lourenço1

Author affiliations

  • 1 Laboratory Of Cancer Genetics, Faculty Of Medical Sciences, Universidade Estadual de Campinas-UNICAMP, 13083-970 - Campinas/BR
  • 2 Department Of Statistics, Institute Of Mathematics, Statistic And Computer Science, Universidade Estadual de Campinas-UNICAMP, 13083-970 - Campinas/BR
  • 3 Department Of Internal Medicine, Faculty Of Medical Sciences, Universidade Estadual de Campinas-UNICAMP, 13083-970 - Campinas/BR
  • 4 Laboratory Of Cell And Molecular Tumor Biology And Bioactive Compounds, São Francisco University, 12916900 - Bragança Paulista/BR


Abstract 4147


Recently, we observed 12,882 new single nucleotide polymorphisms (SNPs) associated with cutaneous melanoma (CM) risk in 103 patients and 103 controls, using large-scale genotyping with microarrays. CREB1 c.303 + 373G>A, involved in melanogenesis and located in regulatory sequence of mRNA processing (splicing), was selected for further analyses. An in silico analysis showed that referred SNP may alters the binding sites of splicing regulatory proteins, such as SF1 and hnRNP A1. However, the role of this SNP in the risk, aggressiveness and prognosis of CM is unknown. Verify whether the distinct genotypes of CREB1 c.303 + 373G>A influence the CM risk and prognosis, clinicopathological aspects, and CREB1, SF1 and HNRNPA1 mRNA levels.


Genomic DNA of 262 patients and 280 controls was analyzed by RT-PCR. Patients were treated with conventional procedures. Gene expressions were determined by qPCR using total RNA of 56 controls. Chi-square, logistic regression model, Mann-Whitney and Student’s t tests analyzed the differences between groups. Progression-free survival (PFS) and overall survival (OS) times were calculated using Kaplan-Meier and Cox regression analyses.


CREB1 GA or AA genotypes were more frequent in CM patients than in controls (72.0% vs. 61.1%, P = 0.02). Carriers of the genotypes were under 1.61-fold increased risk of CM (95% CI: 1.07-2.41) than others. An excess of CREB1 AA variant genotype was seen in patients with Breslow’s thickness higher than 1.5mm (28.2% vs. 18.5%, P = 0.04) and high Clark’s level (26.2% vs. 13.3%, P = 0.02). The median of follow-up of CM patients was 76 months; no association of referred SNP and patients’ PFS and OS was observed in this study. Individuals with CREB1 GA or AA genotypes presented higher mRNA expression of CREB1 (0.94 vs. 0.60 arbitrary units (UAs), P = 0.007), SF1 (1.33 vs. 1.05 UAs, P = 0.03) and HNRNPA1 (0.77 vs. 0.57 UAs, P = 0.02) than those with GG wild-type genotype.


Our data suggest, for the first time, that CREB1 c.303 + 373G>A SNP is an important hereditary factor for the risk and aggressiveness of CM, possibly due to variation of the splicing factors.

Clinical trial identification

Legal entity responsible for the study

University of Campinas


Foundation for protection of research in the state of São Paulo (FAPESP)


All authors have declared no conflicts of interest.

This site uses cookies. Some of these cookies are essential, while others help us improve your experience by providing insights into how the site is being used.

For more detailed information on the cookies we use, please check our Privacy Policy.

Customise settings
  • Necessary cookies enable core functionality. The website cannot function properly without these cookies, and you can only disable them by changing your browser preferences.